INO Stock Summary and Trading Ideas (Inovio Pharmaceuticals | NASDAQ:INO)

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

What symbol and exchange does Inovio Pharmaceuticals shares trade?

Inovio Pharmaceuticals trades on the NASDAQ stock market under the symbol INO.

What is Inovio Pharmaceuticals stock price doing today?

As of March 30, 2026, INO stock price declined to $1.59 with 62,261 million shares trading.

What is Inovio Pharmaceuticals's Beta?

INO has a beta of 1.29, meaning it tends to be more sensitive to market movements. INO has a correlation of 0.07 to the broad based SPY ETF.

How much is Inovio Pharmaceuticals worth?

INO has a market cap of $109.86 million. This is considered a Micro Cap stock.

How much money does Inovio Pharmaceuticals make?

Last quarter Inovio Pharmaceuticals reported $0 in Revenue and -$.26 earnings per share. This fell short of revenue expectation by $-20,000 and exceeded earnings estimates by $.09.

What is the highest and lowest price Inovio Pharmaceuticals traded in the last 3 year period?

In the last 3 years, INO traded as high as $14.75 and as low as $1.30.

What are the top ETFs holding Inovio Pharmaceuticals?

The top ETF exchange traded funds that INO belongs to (by Net Assets): VTI, VXF, IWC.

Is Inovio Pharmaceuticals (INO) a good investment?

INO has underperformed the market in the last year with a price return of -9.7% while the SPY ETF gained +13.5%. INO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.6% and -4.2%, respectively, while the SPY returned -7.6% and -3.7%, respectively.

What are the support and resistance levels for Inovio Pharmaceuticals (INO)?

INO support price is $1.56 and resistance is $1.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INO shares will trade within this expected range on the day.